Expanding the precision oncology toolkit with micro-organospheres for early cancer diagnosis
- PMID: 35659872
- DOI: 10.1016/j.stem.2022.05.002
Expanding the precision oncology toolkit with micro-organospheres for early cancer diagnosis
Abstract
Using an automatic microfluidics droplet platform, Ding et al. successfully replicated the tumor micro-environment by generating micro-organospheres, which were then used to predict the response to anti-tumor drugs. These miniature models could be obtained within an extremely short time frame of 14 days, amplifying their role in facilitating cancer treatment decisions.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests S.C. is the co-founder of OncoBeat, LLC and a member of the Scientific Advisory Board of Cell Stem Cell.
Comment on
-
Patient-derived micro-organospheres enable clinical precision oncology.Cell Stem Cell. 2022 Jun 2;29(6):905-917.e6. doi: 10.1016/j.stem.2022.04.006. Epub 2022 May 3. Cell Stem Cell. 2022. PMID: 35508177 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
